GB9304745D0 - Use of pharmaceutical formulations - Google Patents

Use of pharmaceutical formulations

Info

Publication number: GB9304745D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical formulations; formulations; pharmaceutical
Prior art date: 1993-03-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GB939304745A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Oncholab AB

Original Assignee

Oncholab AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-09

Filing date

1993-03-09

Publication date

1993-04-28

1993-03-09 Application filed by Oncholab AB filed Critical Oncholab AB

1993-03-09 Priority to GB939304745A priority Critical patent/GB9304745D0/en

1993-04-28 Publication of GB9304745D0 publication Critical patent/GB9304745D0/en

1994-03-07 Priority to PCT/GB1994/000432 priority patent/WO1994020145A1/en

1994-03-07 Priority to NZ262160A priority patent/NZ262160A/en

1994-03-07 Priority to SG1996000120A priority patent/SG42848A1/en

1994-03-07 Priority to AU61477/94A priority patent/AU6147794A/en

1994-03-07 Priority to EP94908435A priority patent/EP0688229A1/en

1994-03-07 Priority to JP6519734A priority patent/JPH08509961A/en

1994-03-07 Priority to CA002157761A priority patent/CA2157761A1/en

1994-03-09 Priority to ZA941651A priority patent/ZA941651B/en

Status Pending legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Dispersion Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

GB939304745A 1993-03-09 1993-03-09 Use of pharmaceutical formulations Pending GB9304745D0 (en)

Priority Applications (9)

Application Number	Priority Date	Filing Date	Title
GB939304745A GB9304745D0 (en)	1993-03-09	1993-03-09	Use of pharmaceutical formulations
PCT/GB1994/000432 WO1994020145A1 (en)	1993-03-09	1994-03-07	Use of low density lipoprotein with cytotoxic substances
NZ262160A NZ262160A (en)	1993-03-09	1994-03-07	Anticancer drug with cytotoxic substance formulated with a low density 1ipoprotein
SG1996000120A SG42848A1 (en)	1993-03-09	1994-03-07	Use of low density lipoprotein with cytotoxic substances
AU61477/94A AU6147794A (en)	1993-03-09	1994-03-07	Use of low density lipoprotein with cytotoxic substances
EP94908435A EP0688229A1 (en)	1993-03-09	1994-03-07	Use of low density lipoprotein with cytotoxic substances
JP6519734A JPH08509961A (en)	1993-03-09	1994-03-07	Use of low density lipoproteins and cytotoxic agents
CA002157761A CA2157761A1 (en)	1993-03-09	1994-03-07	Use of low density lipoprotein with cytotoxic substances
ZA941651A ZA941651B (en)	1993-03-09	1994-03-09	Use of low density lipoprotein with cytotoxic substances

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939304745A GB9304745D0 (en)	1993-03-09	1993-03-09	Use of pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
GB9304745D0 true GB9304745D0 (en)	1993-04-28

Family

ID=10731686

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB939304745A Pending GB9304745D0 (en)	1993-03-09	1993-03-09	Use of pharmaceutical formulations

Country Status (9)

Country	Link
EP (1)	EP0688229A1 (en)
JP (1)	JPH08509961A (en)
AU (1)	AU6147794A (en)
CA (1)	CA2157761A1 (en)
GB (1)	GB9304745D0 (en)
NZ (1)	NZ262160A (en)
SG (1)	SG42848A1 (en)
WO (1)	WO1994020145A1 (en)
ZA (1)	ZA941651B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1679934B (en) *	1998-11-09	2012-09-05	生物基因Idec公司	Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
BRPI0009448B8 (en) *	1999-04-01	2021-05-25	Univ Texas	kit for use in treating a neoplasm in a mammal
KR102310697B1 (en)	2012-11-20	2021-10-12	스펙트럼 파마슈티컬즈 인크	Improved method for the preparation of liposome encapsulated vincristine for therapeutic use
TWI678213B (en)	2015-07-22	2019-12-01	美商史倍壯製藥公司	A ready-to-use formulation for vincristine sulfate liposome injection
US11332494B2 (en)	2016-04-29	2022-05-17	Fernando Thome Kreutz	Nanoemulsions and methods for cancer therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0105404A1 (en) *	1982-09-30	1984-04-18	Merck & Co. Inc.	Derivatives of steroid compounds linked to cyotoxic agents and process for their preparation

1993
- 1993-03-09 GB GB939304745A patent/GB9304745D0/en active Pending
1994
- 1994-03-07 NZ NZ262160A patent/NZ262160A/en unknown
- 1994-03-07 JP JP6519734A patent/JPH08509961A/en active Pending
- 1994-03-07 EP EP94908435A patent/EP0688229A1/en not_active Withdrawn
- 1994-03-07 AU AU61477/94A patent/AU6147794A/en not_active Abandoned
- 1994-03-07 SG SG1996000120A patent/SG42848A1/en unknown
- 1994-03-07 CA CA002157761A patent/CA2157761A1/en not_active Abandoned
- 1994-03-07 WO PCT/GB1994/000432 patent/WO1994020145A1/en not_active Application Discontinuation
- 1994-03-09 ZA ZA941651A patent/ZA941651B/en unknown

Also Published As

Publication number	Publication date
AU6147794A (en)	1994-09-26
ZA941651B (en)	1995-09-11
NZ262160A (en)	1997-05-26
WO1994020145A1 (en)	1994-09-15
SG42848A1 (en)	1997-10-17
JPH08509961A (en)	1996-10-22
EP0688229A1 (en)	1995-12-27
CA2157761A1 (en)	1994-09-15

Publication	Publication Date	Title
GB9109862D0 (en)	1991-07-03	Pharmaceutical formulations
GB9103302D0 (en)	1991-04-03	Pharmaceutical formulations
GB9323399D0 (en)	1994-01-05	Pharmaceutical formulations
GB9311030D0 (en)	1993-07-14	Pharmaceutical formulations
GB9201639D0 (en)	1992-03-11	Pharmaceutical formulations
GB9304745D0 (en)	1993-04-28	Use of pharmaceutical formulations
GB9222849D0 (en)	1992-12-16	Novel use of pharmaceutical compositions
GB9304799D0 (en)	1993-04-28	Pharmaceutical formulations
GB9321676D0 (en)	1993-12-08	Pharmaceutical formulations
GB9315119D0 (en)	1993-09-01	Pharmaceutical formulations
GB9314443D0 (en)	1993-08-25	Pharmaceutical formulations
GB9312344D0 (en)	1993-07-28	Pharmaceutical formulations
GB9304800D0 (en)	1993-04-28	Pharmaceutical formulations
GB9304797D0 (en)	1993-04-28	Pharmaceutical formulations
GB9302908D0 (en)	1993-03-31	Pharmaceutical formulations
GB9301250D0 (en)	1993-03-17	Pharmaceutical formulations
GB9204774D0 (en)	1992-04-15	Pharmaceutical formulations
GB9307003D0 (en)	1993-05-26	Pharmaceutical formulations
GB9221244D0 (en)	1992-11-25	Pharmaceutical formulations
GB9207338D0 (en)	1992-05-13	Pharmaceutical formulations
GB9203212D0 (en)	1992-04-01	Pharmaceutical formulations
GB9217602D0 (en)	1992-09-30	Pharmaceutical formulations
GB9221694D0 (en)	1992-12-02	Pharmaceutical formulation
GB9212968D0 (en)	1992-07-29	Pharmaceutical formulation
GB9321346D0 (en)	1993-12-08	Pharmaceutical formulation